BE660244A - - Google Patents

Info

Publication number
BE660244A
BE660244A BE660244A BE660244A BE660244A BE 660244 A BE660244 A BE 660244A BE 660244 A BE660244 A BE 660244A BE 660244 A BE660244 A BE 660244A BE 660244 A BE660244 A BE 660244A
Authority
BE
Belgium
Application number
BE660244A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE660244A publication Critical patent/BE660244A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/10Mercury compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE660244A 1964-02-27 1965-02-25 BE660244A (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6401871A NL6401871A (cs) 1964-02-27 1964-02-27

Publications (1)

Publication Number Publication Date
BE660244A true BE660244A (cs) 1965-08-25

Family

ID=19789406

Family Applications (1)

Application Number Title Priority Date Filing Date
BE660244A BE660244A (cs) 1964-02-27 1965-02-25

Country Status (12)

Country Link
US (1) US3410944A (cs)
AT (4) AT264502B (cs)
BE (1) BE660244A (cs)
BR (1) BR6567446D0 (cs)
CH (3) CH539604A (cs)
DE (1) DE1293782B (cs)
DK (2) DK118827B (cs)
ES (1) ES309809A1 (cs)
FR (2) FR1483718A (cs)
GB (1) GB1111451A (cs)
NL (1) NL6401871A (cs)
SE (1) SE339481B (cs)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023203223A1 (en) 2022-04-22 2023-10-26 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and beta 3-adrenergic receptor agonists, and medical uses thereof
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
WO2024170727A1 (en) 2023-02-16 2024-08-22 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and metformin for use in treating obesity and reducing body fat
WO2024184408A1 (en) 2023-03-06 2024-09-12 Atrogi Ab Combination of beta-2-adrenergic receptor agonists and glp-1 receptor agonists for use in treating hyperglycaemia

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1962497C3 (de) * 1969-12-12 1979-09-20 C.H. Boehringer Sohn, 6507 Ingelheim Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
CN102060716A (zh) * 2009-11-15 2011-05-18 海南中化联合制药工业股份有限公司 一种盐酸利托君的制备方法
IT1399912B1 (it) * 2010-04-29 2013-05-09 Lundbeck Pharmaceuticals Italy S Pa Processo di preparazione di ritodrina cloridrato.
CN102976959B (zh) * 2012-12-07 2014-06-04 许学农 利托君的制备方法
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA623286A (en) * 1961-07-04 N.V. Philips Gloeilampenfabrieken Production of optically active 1-(3',4'-dihydroxyphenyl)-2-amino ethanols
NL86359C (cs) *
US2661373A (en) * 1953-03-02 1953-12-01 Kulz Ida Certain amino alcohols and ketones
BE612995A (fr) * 1961-01-23 1962-07-23 Philips Nv Procédé de préparation d'un nouveau composé à activité optique
AT228786B (de) * 1961-01-23 1963-08-12 Philips Nv Verfahren zur Herstellung des neuen (-)-Enantiomeren des 1-(p-Hydroxyphenyl)-2-(α-methyl- γ-phenyl-propylamino)-propanols-(1) und seiner Säureadditionssalze
US3250803A (en) * 1961-07-06 1966-05-10 Philips Corp Method of manufacturing the individual racemates of n-(p-hydroxyphenylisopropyl) arterenol and products
NL302260A (cs) * 1963-01-24 1900-01-01

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023203223A1 (en) 2022-04-22 2023-10-26 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and beta 3-adrenergic receptor agonists, and medical uses thereof
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
WO2024170727A1 (en) 2023-02-16 2024-08-22 Atrogi Ab Combinations of beta 2-adrenergic receptor agonists and metformin for use in treating obesity and reducing body fat
WO2024184408A1 (en) 2023-03-06 2024-09-12 Atrogi Ab Combination of beta-2-adrenergic receptor agonists and glp-1 receptor agonists for use in treating hyperglycaemia

Also Published As

Publication number Publication date
GB1111451A (en) 1968-04-24
ES309809A1 (es) 1965-07-01
DK118827B (da) 1970-10-12
AT268252B (de) 1969-02-10
US3410944A (en) 1968-11-12
BR6567446D0 (pt) 1973-08-02
AT264502B (de) 1968-09-10
FR4404M (cs) 1966-10-10
NL6401871A (cs) 1965-08-30
DK116740B (da) 1970-02-09
DE1293782B (de) 1969-04-30
AT270618B (de) 1969-05-12
AT261590B (de) 1968-05-10
SE339481B (cs) 1971-10-11
FR1483718A (fr) 1967-06-09
CH472368A (de) 1969-05-15
CH503692A (de) 1971-02-28
CH539604A (de) 1973-07-31

Similar Documents

Publication Publication Date Title
FR4404M (cs)
BE658743A (cs)
BE658581A (cs)
BE642104A (cs)
BE642114A (cs)
BE642212A (cs)
BE642243A (cs)
BE627931A (cs)
BE642316A (cs)
BE642367A (cs)
BE642395A (cs)
BE642400A (cs)
BE627390A (cs)
BE642437A (cs)
BE627057A (cs)
BE637777A (cs)
BE584699A (cs)
BE642470A (cs)
BE642508A (cs)
BE642530A (cs)
BE642588A (cs)
BE642589A (cs)
BE642652A (cs)
BE642654A (cs)
BE642735A (cs)